Ethics declarations Conflict of interest Bartlomiej Kwiek reported serving as a clinical study investigator for AbbVie, Amgen inc, Arcutis Biotherapeuthics, Almirall, Aslan, Bristol-Myers Squibb, Celdex Therapeutics, Celltrion, Dermira, Galderma, Glenmark, Incyte, Janssen Pharmaceuticals, LEO Pharma, Novartis, Pfizer, Regeneron, Samsung
GLP-1s may quiet that food noise, making it easier to focus on healthy eating habits
ACS Appl Mater Interfaces 6(3):19591570
GLP-1: Glucagon-Like Peptide-1 An incretin hormone that stimulates insulin secretion, reduces glucagon release, slows gastric emptying, and Suppresses appetite, aiding weight loss
For the study population with T2DM we conducted a longer follow-up - up to 3 years and observed consistently lower risks in both incident and recurrent AUD associated with semaglutide